HAMLET TO4 B — HAMLET Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK261.96m
- SEK222.34m
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe
Brief: Hamlet Pharma In Discussions With Companies On LoI
Brief: Hamlet Pharma Q1 Pretax Loss Narrows To SEK 1.8 Mln
Brief: Hamlet Pharma Regains Patent Rights For BAMLET
Brief: Hamlet Pharma Q4 Loss Before Tax Narrows To SEK 6.5 Mln
Brief: Hamlet Pharma Signs Contract With European Union
Brief: Hamlet Pharma Q1 Pre-Tax Loss Widens To SEK 6.2 Mln
Brief: Hamlet Pharma Enters Into Patent Licensing Agreement
Brief: Hamlet Pharma Granted EUR 2.2 Mln From Horizon 2020
Brief: Hamlet Pharma Q2 Loss Before Tax Widens To SEK 8.0 Mln
Brief: Hamlet Pharma AB Gets Sek 12,95 mln
Brief: Hamlet Pharma Initiates A GLP Study
Brief: Hamlet Pharma Q1 Loss Before Tax Narrows To SEK 2.7 Mln
Brief: HAMLET Pharma Updates On Alpha1H Treatment
Brief: Hamlet Pharma Gets SEK 12.95 Million Via Exercise Of Warrants
Brief: Hamlet Pharma: Successful Outcome In Alpha1H Clinical Trial
Brief: Hamlet Pharma Q3 Pretax Loss Widens To SEK 5.3 Million